Exact Sciences Corporation (EXAS) by event type

EXAS moves most on coverage initiations — a median of -0.36% at 30 minutes across 27 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the EXAS overview →

By event type

How EXAS reacts across 5 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst downgrades
1,060 of 2,603
46+0.08%74%0.00%
Coverage initiations
1,813 of 2,283
27-0.36%37%+0.88%
Rating reiterations
289 of 3,522
82+0.31%61%+0.36%
Price-target raises
105 of 1,790
21+0.34%67%+0.22%
Price-target cuts
1,261 of 1,527
34-0.20%41%+0.49%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.

That’s how EXAS usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · EXAS overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
KalVista Pharmaceuticals, Inc. (KALV)4380.00%50%
Zymeworks Inc. (ZYME)4380.00%50%
IMMUNE PHARMACEUTICALS INC NE (IMNP)437-0.77%36%
Intec Pharma Ltd (NTEC)437-0.26%36%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.